Group 1: Company Performance and Outlook - The company has improved operational efficiency in 2026 due to adjustments in offline sales channels and team enhancements, expressing confidence in delivering satisfactory results for the year [1] - The net profit margins before and after deducting non-recurring losses for 2024 were 32.78% and 29.94% respectively [2] - The company aims to maintain stable gross margins with offline net profit margins expected to be higher than online [2] Group 2: E-commerce Strategy - The company has established e-commerce teams in Shanghai and Hangzhou, focusing on different platforms to enhance operational capabilities [1] - The Shanghai team is responsible for interest-based e-commerce operations, while the Hangzhou team focuses on shelf-based e-commerce [1] Group 3: Product Development and Innovation - The company has accelerated its product launch pace since the establishment of its R&D center in Shanghai, with a focus on both medical devices and functional skincare products [2] - Collaborative R&D efforts with external institutions aim to enhance product development efficiency and adapt to market competition [3] Group 4: Market Position and Pricing Strategy - The company has maintained stable product pricing, with reasonable fluctuations across main channels, and employs promotional strategies to balance sales and pricing stability [3] - There is ongoing consideration for mergers and acquisitions to enhance R&D capabilities and product offerings [3] Group 5: Brand Strategy - The company has engaged sports celebrities as brand ambassadors to strengthen its professional image and explore innovative marketing paths [2]
敷尔佳(301371) - 2026年3月11日投资者关系活动记录表（一）